Novo Nordisk’s diabetes pill Rybelsus slashes cardiovascular risk
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving…
Read More...
Read More...
Recover your password.
A password will be e-mailed to you.